Pediatric adrenocortical tumors: what they can tell us on adrenal development and comparison with adult adrenal tumors
Enzo eLalli, Bonald C. Figueiredo
Frontiers in Endocrinology · 2015
doi:10.3389/fendo.2015.00023 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Adrenocortical tumors (ACT) in children are very rare and are most frequently diagnosed in the context of the Li-Fraumeni syndrome, a multiple cancer syndrome linked to germline mutations of the tumor suppressor gene TP53 with loss of heterozygosity in the tumors. A peak of children ACT incidence is present in the states of southern Brazil, where they are linked to the high prevalence in the population of a specific TP53 mutation (R337H). Children ACT have specific features distinguishing them from adult tumors in their pathogenetic mechanisms, genomic profiles and prognosis. Epidemiological and molecular evidence suggests that in most cases they are derived from the fetal adrenal.
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.